Published in Vaccine Weekly, September 22nd, 1997
The manufacturer voluntarily recalled 11 lots of the vaccine - already administered to 2 million Americans - after a controversial U.S. Centers for Disease Control and Prevention (CDC) study showed that one of the its three components may have had lowered potency. There were no safety problems with the Parke-Davis product.
"In my own mind, I find it hard to justify a recall on this basis," said Mayo Clinic researcher Gregory Poland in an address to the first annual...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.